ADC Therapeutics S.A. (ADCT)
NYSE · Healthcare
ADC Therapeutics S.A. Gross Profit 2022–2025
ADC Therapeutics S.A. annual/quarterly gross profit history and growth rate from 2022 to 2025. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- ADC Therapeutics S.A. annual gross profit for 2025 was 75.6 M, a 16.45% increase from 2024.
- ADC Therapeutics S.A. annual gross profit for 2024 was 64.9 M, a 2.47% decrease from 2023.
- ADC Therapeutics S.A. annual gross profit for 2023 was 66.5 M, a 7.09% decrease from 2022.
- ADC Therapeutics S.A. annual gross profit for 2022 was 71.6 M.
No data available.
ADC Therapeutics S.A. Gross Profit — FAQ
ADC Therapeutics S.A. (ADCT) gross profit over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is ADC Therapeutics S.A.'s gross profit?
ADC Therapeutics S.A. (ADCT) reported gross profit of $76M for fiscal 2025.
Where can I see ADCT's gross profit history?
The chart and table above show ADC Therapeutics S.A.'s gross profit by year and by quarter, including the growth rate.